O'Connor R - Search Results

1

Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients.

Roche S, O'Neill F, Murphy J, Swan N, Meiller J, Conlon NT, Geoghegan J, Conlon K, McDermott R, Rahman R, Toomey S, Straubinger NL, Straubinger RM, O'Connor R, McVey G, Moriarty M, Clynes M. Roche S, et al. Int J Mol Sci. 2020 Jan 31;21(3):962. doi: 10.3390/ijms21030962. Int J Mol Sci. 2020. PMID: 32024004 Free PMC article.

2

Structure-activity relationship of indomethacin analogues for MRP-1, COX-1 and COX-2 inhibition. identification of novel chemotherapeutic drug resistance modulators.

Touhey S, O'Connor R, Plunkett S, Maguire A, Clynes M. Touhey S, et al. Eur J Cancer. 2002 Aug;38(12):1661-70. doi: 10.1016/s0959-8049(02)00128-4. Eur J Cancer. 2002. PMID: 12142058

3

Methods for generation of monoclonal antibodies to the very small drug hapten, 5-benzimidazolecarboxylic acid.

Moran E, O'Keeffe M, O'Connor R, Larkin AM, Murphy P, Clynes M. Moran E, et al. J Immunol Methods. 2002 Dec 20;271(1-2):65-75. doi: 10.1016/s0022-1759(02)00340-x. J Immunol Methods. 2002. PMID: 12445730

4

Challenges in molecular analysis for individualized cancer therapy.

Clynes M, O'Connor R, O'Driscoll L, Daly C, Meleady P. Clynes M, et al. Drug Discov Today. 2003 Jun 15;8(12):531. doi: 10.1016/s1359-6446(03)02730-2. Drug Discov Today. 2003. PMID: 12821298 No abstract available.

5

Increased anti-tumour efficacy of doxorubicin when combined with sulindac in a xenograft model of an MRP-1-positive human lung cancer.

O'Connor R, Heenan M, Connolly L, Larkin A, Clynes M. O'Connor R, et al. Anticancer Res. 2004 Mar-Apr;24(2A):457-64. Anticancer Res. 2004. PMID: 15152944 Free article.

6

Enhanced in vitro invasiveness and drug resistance with altered gene expression patterns in a human lung carcinoma cell line after pulse selection with anticancer drugs.

Liang Y, O'Driscoll L, McDonnell S, Doolan P, Oglesby I, Duffy K, O'Connor R, Clynes M. Liang Y, et al. Int J Cancer. 2004 Sep 10;111(4):484-93. doi: 10.1002/ijc.20230. Int J Cancer. 2004. PMID: 15239124 Free article.

7

A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin.

Glynn SA, Gammell P, Heenan M, O'Connor R, Liang Y, Keenan J, Clynes M. Glynn SA, et al. Br J Cancer. 2004 Nov 15;91(10):1800-7. doi: 10.1038/sj.bjc.6602221. Br J Cancer. 2004. PMID: 15505620 Free PMC article.

8

MDR1/P-glycoprotein and MRP-1 drug efflux pumps in pancreatic carcinoma.

O'Driscoll L, Walsh N, Larkin A, Ballot J, Ooi WS, Gullo G, O'Connor R, Clynes M, Crown J, Kennedy S. O'Driscoll L, et al. Anticancer Res. 2007 Jul-Aug;27(4B):2115-20. Anticancer Res. 2007. PMID: 17695494 Free article.

9

Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue.

Martinez V, Kennedy S, Doolan P, Gammell P, Joyce H, Kenny E, Prakash Mehta J, Ryan E, O'Connor R, Crown J, Clynes M, O'Driscoll L. Martinez V, et al. Breast Cancer Res Treat. 2008 Aug;110(3):521-30. doi: 10.1007/s10549-007-9739-9. Epub 2007 Sep 27. Breast Cancer Res Treat. 2008. PMID: 17899366

10

Drug resistance in cancer - searching for mechanisms, markers and therapeutic agents.

O'Connor R, Clynes M, Dowling P, O'Donovan N, O'Driscoll L. O'Connor R, et al. Expert Opin Drug Metab Toxicol. 2007 Dec;3(6):805-17. doi: 10.1517/17425255.3.6.805. Expert Opin Drug Metab Toxicol. 2007. PMID: 18028026 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,207 results

Search Page